• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23378 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2009     HAYES, Inc. Robotically assisted nephrectomy for renal malignancy using the da Vinci surgical system (Intuitive Surgical Inc.) for adult patients
2004     HAYES, Inc. Robotically assisted prostatectomy
2011     HAYES, Inc. Robotically assisted stereotactic radiosurgery (SRS) for spinal and extracranial head and neck indications
2011     HAYES, Inc. Robotically assisted stereotactic radiosurgery for intracranial indications
2011     HAYES, Inc. Robotically assisted stereotactic radiosurgery for thoracic and abdominal indications
2004     HAYES, Inc. Robotically assisted stereotactic surgery
2021     Austrian Institute for Health Technology Assessment (AIHTA) Robotics and functional electrical stimulation for stroke rehabilitation: systematic review
2015     NIHR Horizon Scanning Centre (NIHR HSC) ROCA® for the diagnosis of ovarian cancer
2015     NIHR Horizon Scanning Centre (NIHR HSC) Rociletinib for advanced or recurrent non-small cell lung cancer with the EGFR T790M mutation
2021     NIHR Health Technology Assessment programme ROCkeTS - Refining Ovarian Cancer Test Accuracy Scores
2009     NIHR Horizon Scanning Centre (NIHR HSC) Roflumilast (Daxas) for chronic obstructive pulmonary disease
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Roflumilast for asthma and chronic obstructive pulmonary disease
2004     NIHR Horizon Scanning Centre (NIHR HSC) Roflumilast for asthma and chronic obstructive pulmonary disease - horizon scanning review
2011     NIHR Health Technology Assessment programme Roflumilast for the management of severe chronic obstructive pulmonary disease
2017     National Institute for Health and Care Excellence (NICE) Roflumilast for treating chronic obstructive pulmonary disease. NICE technology appraisal guidance 461
2015     HAYES, Inc. Rolapitant (Varubi) in combination with other antiemetic drugs to prevent delayed nausea and vomiting from cancer chemotherapy
2007     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Role and positioning of university outpatient departments
2011     Agency for Healthcare Research and Quality (AHRQ) Role of active surveillance in the management of men with localized prostate cancer
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Role of anti cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Role of anti cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis
2005     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Role of combination inhaled corticosteroids and long acting beta agonists in the treatment of adult asthma
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Role of CT scan and magnetic resonance imaging in pancreatic cyst diagnosis
2018     Agency for Healthcare Research and Quality (AHRQ) Role of immunotherapy in the treatment of asthma
2006     The Swedish Council on Health Technology Assessment (SBU) Role of natriuretic peptides in diagnosing heart failure - early assessment briefs (Alert)
2024     Austrian Institute for Health Technology Assessment (AIHTA) Role of public contributions to the development of health innovations and its integration in value assessment and pricing/reimbursement decisions
2013     Health Quality Ontario (HQO) Role of screening for respiratory syncytial virus or influenza and empirical antiviral treatment for patients with community-acquired pneumonia: a rapid review
2008     Health Council of the Netherlands Gezondheidsraad (GR) Role redefinition in health care
2020     European Network for Health Technology Assessment (EUnetHTA) Rolling Collaborative Review COVID-19 - Lopinavir + Ritonavir
2021     Health Information and Quality Authority (HIQA) Rolling summary of the evidence in relation to the Omicron (B.1.1.529) variant
2008     NIHR Horizon Scanning Centre (NIHR HSC) Rolofylline for acute heart failure
2011     NIHR Horizon Scanning Centre (NIHR HSC) Romidepsin (Istodax) for peripheral T-cell lymphoma, relapsed and/or refractory - second line
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Romidepsin (Istodax®) for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) after prior systemic therapy
2011     National Institute for Health and Care Excellence (NICE) Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura
2009     NIHR Health Technology Assessment programme Romiplostim for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a single technology appraisal
2023     Agency for Care Effectiveness (ACE) Romosozumab and teriparatide for treating osteoporosis
2022     National Institute for Health and Care Excellence (NICE) Romosozumab for treating severe osteoporosis. NICE technology appraisal guidance 791
2003     NIHR Horizon Scanning Centre (NIHR HSC) Ropinirole for idiopathic restless legs syndrome - horizon scanning review
2009     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ropinirole prolonged-release (Requip XL®) for the treatment of idiopathic Parkinson's disease
2000     University HealthSystem Consortium (UHC) Rosiglitazone
2005     NIHR Horizon Scanning Centre (NIHR HSC) Rosiglitazone maleate for moderate to severe plaque psoriasis - horizon scanning review
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Rosuvastatin
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Rosuvastatin (Crestor®)
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Rosuvastatin: do we need another statin?
2010     HAYES, Inc. Rotating platform knee arthroplasty
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Rotigotine (Neupro - UCB Canada Inc.) indication: idiopathic Parkinson disease (early and advanced)
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Rotigotine (Neupro — UCB Canada Inc.) indication: idiopathic parkinson disease (early and advanced)
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Rotigotine transdermal patches (Neupro) for the treatment of Parkinson's disease.
1993     Health Services Utilization and Research Commission (HSURC) Routine admission testing
2009     NIHR Health Technology Assessment programme Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation
2009     NIHR Health Technology Assessment programme Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Routine blood tests for patients in the intensive care unit: clinical effectiveness, cost-effectiveness, and guidelines
1999     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Routine CXR In routine medical examination
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Routine dental care programs in long term care: a review of the clinical effectiveness and guidelines
2023     Canadian Agency for Drugs and Technologies in Health (CADTH) Routine dental polishing for oral health
2014     NIHR Health Technology Assessment programme Routine echocardiography in the management of stroke and transient ischaemic attack: a systematic review and economic evaluation
2004     NIHR Health Technology Assessment programme Routine examination of the newborn: the EMREN study. Evaluation of an extension of the midwife role including a randomised controlled trial of appropriately trained midwives and paediatric senior house officers
2006     Medical Advisory Secretariat (MAS) Routine eye examinations for persons 20-64 years of age: an evidence-based analysis
2015     Agency for Healthcare Research and Quality (AHRQ) Routine iron supplementation and screening for iron deficiency anemia in children ages 6 to 24 months: a systematic review to update the U.S. Preventive Services Task Force Recommendation
2015     Agency for Healthcare Research and Quality (AHRQ) Routine iron supplementation and screening for iron deficiency anemia in pregnant women
2018     NIHR Health Technology Assessment programme Routine low-dose continuous or nocturnal oxygen for people with acute stroke: three-arm Stroke Oxygen Supplementation RCT
2002     Malaysian Health Technology Assessment Unit (MHTAU) Routine neonatal vitamin K administration at birth
2001     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Routine neonatal vitamin K administration in newborn
2010     Penn Medicine Center for Evidence-based Practice (CEP) Routine newborn monitoring immediately following birth
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Routine ordering of primary pathology examinations in Canada
2006     National Institute for Health and Care Excellence (NICE) Routine postnatal care of women and their babies
1996     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Routine pre-operative investigation
1994     University HealthSystem Consortium (UHC) Routine preoperative diagnostic evaluations
2010     Institute of Health Economics (IHE) Routine preoperative electrocardiogram and chest x-ray prior to elective surgery in Alberta, Canada
1997     NIHR Health Technology Assessment programme Routine preoperative testing: a systematic review of the evidence
2007     Institute of Health Economics (IHE) Routine preoperative tests - are they necessary?
2000     NIHR Health Technology Assessment programme Routine referral for radiography of patients presenting with low back pain: is patients' outcome influenced by GPs' referral for plain radiography?
2013     Penn Medicine Center for Evidence-based Practice (CEP) Routine replacement of peripheral intravenous catheters
1999     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Routine skull x-rays in head injury
2010     HAYES, Inc. Routine ultrasound examination in low-risk pregnancy
1996     British Columbia Office of Health Technology Assessment (BCOHTA) Routine ultrasound imaging in pregnancy: how evidence-based are the guidelines?
1998     The Swedish Council on Health Technology Assessment (SBU) Routine ultrasound in pregnancy
2004     Quality Improvement Scotland (NHS QIS ) Routine ultrasound scanning before 24 weeks of pregnancy; HTA Advice 5: Routine ultrasound scanning before 24 weeks of pregnancy; Understanding our Advice: Routine ultrasound scanning before 24 weeks of pregnancy
2003     Agency for Healthcare Research and Quality (AHRQ) Routine vitamin supplementation to prevent cancer
2003     Agency for Healthcare Research and Quality (AHRQ) Routine vitamin supplementation to prevent cardiovascular disease
2014     HAYES, Inc. Roux-en-Y gastric bypass for diabetes in obese or severely obese patients
2013     HAYES, Inc. Roux-en-Y gastric bypass for gastroesophageal reflux disease in obese or severely obese patients
2017     HAYES, Inc. Roux-en-Y gastric bypass for treatment of Type II Diabetes: a review of reviews
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) ROX Coupler for treatment-resistant hypertension
2022     National Institute for Health and Care Excellence (NICE) Roxadustat for treating symptomatic anaemia in chronic kidney disease. NICE technology appraisal guidance 807
2003     NIHR Horizon Scanning Centre (NIHR HSC) Rubitecan resistant refractory pancreatic cancer - horizon scanning review
2003     NIHR Horizon Scanning Centre (NIHR HSC) Ruboxistaurin for diabetic neuropathy - horizon scanning review
2006     Canadian Agency for Drugs and Technologies in Health (CADTH) Ruboxistaurin mesylate hydrate
2016     NIHR Horizon Scanning Centre (NIHR HSC) Rucaparib for advanced BRCA-mutated ovarian cancer
2019     National Institute for Health and Care Excellence (NICE) Rucaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer. NICE technology appraisal guidance 611
2012     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Rufinamide (Inovelon®) 40 mg/ml oral suspension
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Rufinamide (Inovelon®) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS)
2000     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Ruptured intracranial aneurysm: endovascular occlusion versus microsurgical clipping
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ruxolitinib (Jakavi) for polycythaemia vera – second line
2010     NIHR Horizon Scanning Centre (NIHR HSC) Ruxolitinib for myelofibrosis - first line
2012     NIHR Health Technology Assessment programme Ruxolitinib for the treatment of myelofibrosis
2022     National Institute for Health and Care Excellence (NICE) Ruxolitinib for treating acute graft versus host disease refractory to corticosteroids (terminated appraisal). NICE technology appraisal guidance 839
2022     National Institute for Health and Care Excellence (NICE) Ruxolitinib for treating chronic graft versus host disease refractory to corticosteroids (terminated appraisal). NICE technology appraisal guidance 840
2016     National Institute for Health and Care Excellence (NICE) Ruxolitinib for treating disease-related splenomegaly or symptoms in adults with myelofibrosis. NICE technology appraisal guidance 386
2022     Agency for Care Effectiveness (ACE) Ruxolitinib for treating polycythaemia vera
2023     National Institute for Health and Care Excellence (NICE) Ruxolitinib for treating polycythaemia vera. NICE technology appraisal guidance 921